| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Zhou Jianxiang | Chief Technology Officer | 8/F, DESHENG HOPSON FORTUNE PLAZA, 13-1, DESHENGMENWAI AVENUE, XICHENG DISTRICT, BEIJING, CHINA | /s/ Jianxiang Zhou | 16 Mar 2026 | 0002026211 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CCG | Class A Common Stock | 1,640,350 | 16 Mar 2026 | Direct | ||||||
| holding | CCG | Restricted Stock | 1,093,567 | 16 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CCG | Stock Option | 16 Mar 2026 | Class A Common Stock | 3,000 | $0.1000 | Direct | F2 | ||||||
| holding | CCG | Stock Option | 16 Mar 2026 | Class A Common Stock | 3,000 | $0.1000 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents the grant of restricted stock to the Reporting Person on January 1, 2023, under the Issuer's 2019 Equity Incentive Plan. All of the restricted stock was fully vested upon grant, but was subject to time-based transfer restrictions. Such restrictions will lapse, and the shares will become transferable upon the date that is 30 months following the Company's initial public offering date ("IPO" date). |
| F2 | On March 1, 2024, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted stock options to purchase an aggregate of 3,000 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options are exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date. |
| F3 | On March 31, 2025, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted stock options to purchase an aggregate of 3,000 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options become exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date. |